Skip to main content

Advertisement

Table 4 The average brown florescence in each group (%) (n = 5)

From: Assessment of the hepatocyte protective effects of gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes

Group Drug concentration (μg/mL) Average brown florescence rate (%)
CC 0 11.70 ± 0.15d
VC 0 35.89 ± 1.07a
GPC 100 12.81 ± 0.25d
pGPC 25 12.42 ± 0.10d
GP 100 18.47 ± 0.21b
pGP 25 14.99 ± 0.43c
  1. Note: Data in the same column, marked with different letters indicates a significant difference (p < 0.05). CC group Cell control group, VC group Virus control group, GPC group Gypenoside control group, pGPC Phosphorylated gypenoside control group, E Gypenoside group, F Phosphorylated gypenoside group